Nathaniel James Rhodes

53PUBLICATIONS
78CO-AUTHORS
Medical microbiology not elsewhere classifiedPharmacogenomicsClinical pharmacology and therapeuticsCell physiologyEconomic models and forecasting
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (53)

|Sep 04, 2026
L2 β-lactamase contributes to ceftolozane-tazobactam resistance in Pseudomonas aeruginosa.

|Sep 04, 2026
Volumetric Microsampling for Patient-Centric Therapeutic Drug Monitoring in Clinical Pharmacology: A Scoping Review.

|Jul 23, 2026
Consensus Guidance for Beta-Lactam Antibiotic Dose Individualization in Acutely Ill Patients: Endorsed by the American College of Clinical Pharmacy, European Society of Clinical Microbiology and Infectious Diseases, European Society of Clinical Microbiology and Infectious Diseases PK/PD of Anti-Infectives Study Group, Infectious Diseases Society of America, International Association of Therapeutic Drug Monitoring and Clinical Toxicology, Society of Critical Care Medicine, and the Society of Infectious Diseases Pharmacists.

|Jul 10, 2026
Predictive accuracy of population meropenem models in critically ill pneumonia patients.

|Jun 11, 2026
Defining Optimal Sampling Strategies for Cefepime Model-Informed Precision Dosing.

|Jun 11, 2026
Toward the Future: A Race-Agnostic, Bayesian Approach to Defining Glomerular Filtration for Personalized Drug Dosing.

Pageof 9

Frequent Collaborators

36 joint publications

Marc Scheetz

15 joint publications

Sean N Avedissian

9 joint publications

Michael Neely

7 joint publications

Adrian Valadez